These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17709502)

  • 1. CCL19 and CXCL13 synergistically regulate interaction between B cell acute lymphocytic leukemia CD23+CD5+ B Cells and CD8+ T cells.
    Wang X; Yuling H; Yanping J; Xinti T; Yaofang Y; Feng Y; Ruijin X; Li W; Lang C; Jingyi L; Zhiqing T; Jingping O; Bing X; Li Q; Chang AE; Sun Z; Youxin J; Jinquan T
    J Immunol; 2007 Sep; 179(5):2880-8. PubMed ID: 17709502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
    Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
    J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
    Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
    Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
    Qiuping Z; Jie X; Youxin J; Qun W; Wei J; Chun L; Jin W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Qun L; Kejian Z; Zhimin S; Junyan L; Jinquan T
    Oncogene; 2005 Jan; 24(4):573-84. PubMed ID: 15580304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD5 and CD23 expression on B cells in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with interleukin-4, soluble CD23 and tumour necrosis factor alpha levels.
    Loza E; Tinturé T; Sánchez-Ibarrola A
    Rheumatology (Oxford); 1999 Apr; 38(4):325-8. PubMed ID: 10378709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CD23 is a consequence of B-cell activation. Implications for the analysis of B-cell lineages.
    Rabin E; Cong YZ; Wortis HH
    Ann N Y Acad Sci; 1992 May; 651():130-42. PubMed ID: 1376028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts.
    Fournier S; Tran ID; Suter U; Biron G; Delespesse G; Sarfati M
    Leuk Res; 1991; 15(7):609-18. PubMed ID: 1830631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR5
    Tang J; Zha J; Guo X; Shi P; Xu B
    Int Immunopharmacol; 2017 Sep; 50():146-151. PubMed ID: 28662433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines.
    Picchio MC; Scala E; Pomponi D; Caprini E; Frontani M; Angelucci I; Mangoni A; Lazzeri C; Perez M; Remotti D; Bonoldi E; Benucci R; Baliva G; Lombardo GA; Napolitano M; Russo G; Narducci MG
    Cancer Res; 2008 Sep; 68(17):7137-46. PubMed ID: 18757429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis.
    Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A
    Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL19 enhances CD8
    Yan Y; Zhao W; Liu W; Li Y; Wang X; Xun J; Davgadorj C
    J Gastroenterol; 2021 Aug; 56(8):769-785. PubMed ID: 34218330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation and down-regulation of cell surface and mRNA expression of CD5 antigen by various humoral factors on murine 70Z/3 pre-B cell leukemia cell line: IL-4 down-regulates CD5 antigen expression.
    Jyonouchi H; Voss RM; Good RA
    Cell Immunol; 1990 Oct; 130(1):66-78. PubMed ID: 1697787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine control of memory B cell homing machinery.
    Roy MP; Kim CH; Butcher EC
    J Immunol; 2002 Aug; 169(4):1676-82. PubMed ID: 12165486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
    Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
    Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.
    Xing C; Ma N; Xiao H; Wang X; Zheng M; Han G; Chen G; Hou C; Shen B; Li Y; Wang R
    J Leukoc Biol; 2015 Mar; 97(3):547-56. PubMed ID: 25516754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T; Vanbervliet B; Durand I; Banchereau J
    Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of CD40- and interleukin (IL-4)-activated CD23+ cells on the production of IL-10 by mononuclear cells in Graves' disease: the role of CD8+ cells.
    Uchimura K; Itoh M; Yamamoto K; Imamura S; Makino M; Kato T; Fujiwara K; Sawai Y
    Clin Exp Immunol; 2002 May; 128(2):308-12. PubMed ID: 11985521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia.
    Fournier S; Yang LP; Delespesse G; Rubio M; Biron G; Sarfati M
    Br J Haematol; 1995 Feb; 89(2):373-9. PubMed ID: 7873388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.